ArticleP & T : a peer-reviewed journal for formulary management2017

The Use of Idarucizumab for Dabigatran Reversal in Clinical Practice: A Case Series.

Pavel Goriacko et al.PubMed ↗Full text ↗

No numbers read from the abstract.